BIIO

Bionovate Technologies Corp. [BIIO] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BIIO Stock Summary

In the News

BIIO Financial details

Company Rating
-
Market Cap
8
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.03
Forward P/E
-
PEG
-
P/S
-
P/B
-0.01
P/C
-
P/FCF
-3.28
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
37%
ROC
0.09%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.0E-6-1.0E-4
52W High
-
52W Low
-
RSI
52.12
Rel Volume
-
Avg Volume
-
Volume
1
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
2.497
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0001
Change
0%

Something similar

Top by Market Cap
3V64.DE
AVGO
LLY.DE
TSLA
VFINX
Same Sector
CZMWY
OPTN
1177.HK
0512.HK
4151.T
Check Those
0RTK.L
1759.HK
SBT.TO
3003.TW
600315.SS
Similar Market Cap
TRITF
KGJI
BIIO
FXCOW
GNRSW

Company Profile

Healthcare Medical - Devices
  • Market Capitalization 8
  • CEO Mr. Timothy Jones
  • Headquarters Cham,CH
  • IPO Date 2014-06-12
  • Website https://bionovate.com

Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide. The company was formerly known as MJP International Ltd. and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland. As of October 7, 2020, Bionovate Technologies Corp. operates as a subsidiary of Human Data AG.